Artificial intelligence takes on liver disease detection
NCT ID NCT07305636
Summary
This study tested whether artificial intelligence (AI) models could better detect liver scarring in people with fatty liver disease compared to traditional blood tests. Researchers analyzed data from 522 Egyptian adults with metabolic-associated fatty liver disease (MAFLD) who had undergone FibroScan testing. The goal was to see if AI could provide more accurate, non-invasive diagnosis of liver fibrosis, potentially reducing the need for liver biopsies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAFLD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faculty of Medicine
Tanta, Egypt
Conditions
Explore the condition pages connected to this study.